Research Page

This page provides key findings from recent research on Long COVID, aiming to share valuable insights into this complex condition. Disclaimer: The author of this page is not a doctor or medical professional. All information presented here is based on research and articles from the references listed below. While every effort has been made to ensure accuracy and relevance, no guarantee can be made regarding the completeness or correctness of the information. The content on this page is intended for informational purposes only and does not constitute medical advice. Anyone seeking medical care or advice should consult a qualified healthcare provider for professional guidance. The goal is to inform and provide a resource for those interested in learning more about Long COVID. Any additional research articles or insights are always welcome for review. You can skip to the relevant research articles at the bottom of the page.

Long COVID: Understanding Your Recovery Journey

Long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), refers to symptoms that persist for weeks or months after the acute phase of a COVID-19 infection. The good news is that most people improve over time, and many experience significant recovery within the first year. Here’s what you need to know.

Common Symptoms of Long COVID

Long COVID can manifest with a variety of symptoms. The most common ones include:

  • Fatigue: A persistent feeling of tiredness that is not relieved by rest [1, 12, 18].
  • Brain Fog: Difficulty with memory, concentration, or mental clarity, linked to serotonin reductions and immune dysregulation [16, 2, 12].
  • Shortness of Breath: Feeling breathless even during normal activities [1, 4].
  • Muscle and Joint Pain: Ongoing aches, stiffness, or tenderness [2, 5].
  • Sleep Issues: Difficulty falling asleep or waking up unrefreshed [9, 15].
  • Cardiovascular Symptoms: Some individuals may experience chest pain, palpitations, or high blood pressure. Research shows COVID-19 survivors are at increased risk for these complications, with younger individuals reporting a higher prevalence of chest pain [19].

For Those Still Suffering Beyond 12 Months

While most people experience significant recovery within a year, a subset of patients continues to struggle with persistent symptoms. If you are still experiencing Long COVID beyond 12 months, you are not alone. New research suggests that individuals may continue to recover beyond one year, with some experiencing slow but steady symptom improvement even after 24 months [11, 18].

Emerging therapies, such as immune-based treatments and symptom-targeted interventions, show promise for those with ongoing symptoms [5, 12]. Research also indicates that **immune stabilization and inflammation reduction** play a key role in later recovery phases, offering new opportunities for symptom management.

Why Do These Milestones Matter?

  • Immune System Adjustment: The immune system gradually stabilizes, leading to reduced inflammation and symptom relief [12, 13].
  • Serotonin Levels: Some Long COVID patients have lower serotonin levels, affecting mood and cognition. As serotonin levels normalize, brain fog and memory issues often improve [16].

Readily Available and Effective Treatments

Some treatments have been found effective in symptom relief and are widely accessible:

  • Compression Socks: Help improve circulation and manage POTS-like symptoms, reducing dizziness and promoting better blood flow [18].
  • Antihistamines: Both H1 and H2 antihistamines (such as fexofenadine and famotidine) have shown effectiveness in improving symptoms linked to mast cell activation, including fatigue, brain fog, and cardiovascular issues [2, 3, 7].
  • Pacing and Energy Management: Many patients with post-viral fatigue benefit from carefully managing exertion to prevent symptom flare-ups [18].
  • Anti-Inflammatory Therapies: Research suggests that **targeting immune dysregulation and thromboinflammation** may help reduce symptoms in some Long COVID patients [5, 6].

Proven Anti-Inflammatory Supplements

Several supplements have demonstrated anti-inflammatory or immune-modulating effects in post-viral syndromes:

  • Omega-3 Fatty Acids (Fish Oil): May help reduce systemic inflammation and support cognitive function [5, 12].
  • Curcumin (Turmeric Extract): Has known anti-inflammatory properties and may assist in reducing immune overactivation [6].
  • N-Acetylcysteine (NAC): Supports glutathione production and has been studied for its potential to reduce oxidative stress and inflammation [18].
  • Quercetin: A flavonoid with antihistamine and anti-inflammatory properties, potentially beneficial for those experiencing mast cell activation symptoms [2, 3].

Mental Health Aspects of Long COVID

Long COVID can impact mental health, with many individuals experiencing increased levels of anxiety, low mood, or depression. This is often due to a combination of ongoing physical symptoms, uncertainty about recovery, and lifestyle limitations [4, 12].

  • Anxiety and Depression: Studies confirm that symptoms like fatigue, brain fog, and breathlessness can lead to increased psychological distress, even in previously healthy individuals [4, 12].
  • Support and Recovery: Seeking mental health support, such as counseling or support groups, can be beneficial. A holistic approach that includes both physical and mental well-being has shown promise in aiding recovery.

A Positive Outlook

The majority of Long COVID patients experience steady improvement, and research continues to highlight positive recovery trajectories. While the pace of recovery varies, studies show that gradual healing is the norm [6, 9, 13].

Although Long COVID can be challenging, medical advancements are rapidly unfolding. Research is continuously improving our understanding of the condition, paving the way for new treatment options. In the meantime, **pacing, symptom management, and self-care remain valuable tools in your recovery journey**.

Research Articles
… from the last 2 to 3 years

References

Below is a list of recent peer-reviewed research articles relating to Long COVID, which shows promising results and aids in our understanding of this disease.

If there are research articles which you have found both interesting and useful, please contact us to let us have a look, be sure to include a link.

  1. O’Mahoney, L.L., et al. (2023). The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine. [DOI: 10.1016/j.eclinm.2022.101762]

  2. Sumantri, S., et al. (2023). Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pacific Allergy. [DOI: 10.5415/apallergy.0000000000000022]

  3. Weinstock, L.B., et al. (2021). Mast cell activation symptoms are prevalent in Long-COVID. International Journal of Infectious Diseases. [DOI: 10.1016/j.ijid.2021.10.024]

  4. Porter, C.K., et al. (2024). Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study. The Lancet Regional Health – Americas. [DOI: 10.1016/j.lana.2024.100909]

  5. Cervia-Hasler, C., et al. (2024). Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science. [DOI: 10.1126/science.eadg7942]

  6. Peluso, M.J., et al. (2024). Mechanisms of Long COVID and the Path Toward Therapeutics. Cell. [DOI: 10.1016/j.cell.2024.07.054]

  7. Salvucci, F., et al. (2023). Antihistamines Improve Cardiovascular Manifestations and Other Symptoms of Long-COVID Attributed to Mast Cell Activation. Frontiers in Cardiovascular Medicine. [DOI: 10.3389/fcvm.2023.1202696]

  8. Diexer, S., et al. (2024). Insights into Early Recovery from Long COVID—Results from the German DigiHero Cohort. Scientific Reports. [DOI: 10.1038/s41598-024-59122-3]

  9. Takakura, K., et al. (2022). Clinical Features, Therapeutic Outcomes, and Recovery Period of Long COVID. Journal of Medical Virology. [DOI: 10.1002/jmv.28316]

  10. Rua, C., et al. (2024). Quantitative Susceptibility Mapping at 7 T in COVID-19: Brainstem Effects and Outcome Associations. Brain. [DOI: 10.1093/brain/awae215]

  11. Astin, R., et al. (2023). Long COVID: Mechanisms, Risk Factors, and Recovery. Experimental Physiology. [DOI: 10.1113/EP090802]

  12. Phetsouphanh, C., et al. (2024). Improvement of Immune Dysregulation in Individuals with Long COVID at 24 Months Following SARS-CoV-2 Infection. Nature Communications. [DOI: 10.1038/s41467-024-47720-8]

  13. Hartung, T.J., et al. (2024). Predictors of Non-Recovery from Fatigue and Cognitive Deficits After COVID-19: A Prospective, Longitudinal, Population-Based Study. EClinicalMedicine. [DOI: 10.1016/j.eclinm.2024.102456]

  14. Qin, S., et al. (2024). Long COVID Facts and Findings: A Large-Scale Online Survey in 74,075 Chinese Participants. The Lancet Regional Health – Western Pacific. [DOI: 10.1016/j.lanwpc.2024.101218]

  15. Davis, H.E., et al. (2023). Long COVID: Major Findings, Mechanisms, and Recommendations. Nature Reviews Microbiology. [DOI: 10.1038/s41579-022-00846-2]

  16. Wong, A.C., et al. (2023). Serotonin Reduction in Post-Acute Sequelae of Viral Infection. Cell. [DOI: 10.1016/j.cell.2023.09.013]

  17. Vernon, S.D., Zheng, T., Do, H., et al. (2025). Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study. Journal of General Internal Medicine. [DOI: 10.1007/s11606-024-09290-9]

  18. Eckey, M., et al. (2025). New Insights into the Long-Term Recovery Patterns in Long COVID Patients. BMC Medicine. [DOI: 10.1186/s12916-025-03908-3]

  19. Xiong, R., et al. (2025). Long-Term Cardiovascular Complications in Post-COVID Patients: A Systematic Review and Meta-Analysis. European Heart Journal. [DOI: 10.1093/eurheartj/ehae025]